BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lowe H, Toyang N, Steele B, Valentine H, Grant J, Ali A, Ngwa W, Gordon L. The Therapeutic Potential of Psilocybin. Molecules 2021;26:2948. [PMID: 34063505 DOI: 10.3390/molecules26102948] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Lee HJ, Stein MB. Update on treatments for anxiety-related disorders. Curr Opin Psychiatry 2023;36:140-5. [PMID: 36480651 DOI: 10.1097/YCO.0000000000000841] [Reference Citation Analysis]
2 Mastinu A, Anyanwu M, Carone M, Abate G, Bonini SA, Peron G, Tirelli E, Pucci M, Ribaudo G, Oselladore E, Premoli M, Gianoncelli A, Uberti DL, Memo M. The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology. Int J Mol Sci 2023;24. [PMID: 36674849 DOI: 10.3390/ijms24021329] [Reference Citation Analysis]
3 Buzzelli V, Carbone E, Manduca A, Schiavi S, Feo A, Perederiy JV, Ambert KH, Hausman M, Trezza V. Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome. Psychopharmacology (Berl) 2023;240:137-47. [PMID: 36469097 DOI: 10.1007/s00213-022-06286-3] [Reference Citation Analysis]
4 Bradshaw AJ, Backman TA, Ramírez-Cruz V, Forrister DL, Winter JM, Guzmán-Dávalos L, Furci G, Stamets P, Dentinger BTM. DNA Authentication and Chemical Analysis of Psilocybe Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites. Appl Environ Microbiol 2022;88:e0149822. [PMID: 36445079 DOI: 10.1128/aem.01498-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bradshaw AJ, Ramírez-cruz V, Awan AR, Furci G, Guzmán-dávalos L, Stamets P, Dentinger BT. Phylogenomics of the psychoactive mushroom genusPsilocybeand evolution of the psilocybin biosynthetic gene cluster.. [DOI: 10.1101/2022.12.13.520147] [Reference Citation Analysis]
6 Turkia M. Self-treatment of psychosis and complex post-traumatic stress disorder with LSD and DMT—A retrospective case study. Psychiatry Research Case Reports 2022;1:100029. [DOI: 10.1016/j.psycr.2022.100029] [Reference Citation Analysis]
7 Strauss D, Ghosh S, Murray Z, Gryzenhout M. Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields. 3 Biotech 2022;12:339. [DOI: 10.1007/s13205-022-03355-4] [Reference Citation Analysis]
8 Hartogsohn I, Petranker R. Set and setting in microdosing: an oft-overlooked principle. Psychopharmacology 2022. [DOI: 10.1007/s00213-022-06249-8] [Reference Citation Analysis]
9 Danias G, Appel J. A Google Trends analysis of public interest in psilocybin in the context of the COVID-19 pandemic (Preprint).. [DOI: 10.2196/preprints.43850] [Reference Citation Analysis]
10 Goel DB, Zilate S. Potential Therapeutic Effects of Psilocybin: A Systematic Review. Cureus 2022;14:e30214. [PMID: 36381758 DOI: 10.7759/cureus.30214] [Reference Citation Analysis]
11 Erkizia-santamaría I, Alles-pascual R, Horrillo I, Meana J, Ortega J. Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response. Biomedicine & Pharmacotherapy 2022;154:113612. [DOI: 10.1016/j.biopha.2022.113612] [Reference Citation Analysis]
12 Psiuk D, Nowak EM, Dycha N, Łopuszańska U, Kurzepa J, Samardakiewicz M. Esketamine and Psilocybin—The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review. IJMS 2022;23:11450. [DOI: 10.3390/ijms231911450] [Reference Citation Analysis]
13 Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, Offman H, Parikh SV, Frey BN, Schaffer A, Greenwaym KT, Garel N, Beaulieu S, Kennedy SH, Lam RW, Milev R, Ravindran AV, Tourjman V, Ameringen MV, Yatham LN, Taylor V. The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder. Can J Psychiatry 2022;:7067437221111371. [PMID: 35975555 DOI: 10.1177/07067437221111371] [Reference Citation Analysis]
14 Williams K, Romero OSG, Braunstein M, Brant S. Indigenous Philosophies and the "Psychedelic Renaissance". Anthropol of Consciousness. [DOI: 10.1111/anoc.12161] [Reference Citation Analysis]
15 Plesa P, Petranker R. Manifest your desires: Psychedelics and the self-help industry. International Journal of Drug Policy 2022;105:103704. [DOI: 10.1016/j.drugpo.2022.103704] [Reference Citation Analysis]
16 Sotille R, Singh H, Weisman A, Vida T. Unraveling the Mysteries of Mental Illness With Psilocybin. Cureus 2022;14:e25414. [PMID: 35769681 DOI: 10.7759/cureus.25414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Lowe H, Toyang N, Steele B, Grant J, Ali A, Gordon L, Ngwa W. Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders. Molecules 2022;27:2520. [DOI: 10.3390/molecules27082520] [Reference Citation Analysis]
18 De Silva PN. Neurobiological and epigenetic perspectives on hedonism, altruism and conscience. BJPsych advances. [DOI: 10.1192/bja.2022.16] [Reference Citation Analysis]
19 Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR. Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review. Cureus 2022. [DOI: 10.7759/cureus.21944] [Reference Citation Analysis]
20 Van Court R, Wiseman M, Meyer K, Ballhorn D, Amses K, Slot J, Dentinger B, Garibay-orijel R, Uehling J. Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development. Fungal Biology 2022. [DOI: 10.1016/j.funbio.2022.01.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
21 Tavassoli M, Afshari A, Mégarbane B, Rezaee R. Mushrooms, psilocybin. Reference Module in Biomedical Sciences 2022. [DOI: 10.1016/b978-0-12-824315-2.00087-7] [Reference Citation Analysis]
22 Clauss NJ, Daws LC. Neurotransmitter Transporters and Their Role in the Pharmacological Actions of Therapeutic and Abused Drugs. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00172-9] [Reference Citation Analysis]
23 Elman I, Pustilnik A, Borsook D. Beating Pain with Psychedelics: Matter over Mind? Neurosci Biobehav Rev 2021:S0149-7634(21)00553-4. [PMID: 34922987 DOI: 10.1016/j.neubiorev.2021.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Castelhano J, Lima G, Teixeira M, Soares C, Pais M, Castelo-Branco M. The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies. Front Pharmacol 2021;12:739053. [PMID: 34658876 DOI: 10.3389/fphar.2021.739053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]